Prasad H. Kari

436 total citations
9 papers, 355 citations indexed

About

Prasad H. Kari is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Prasad H. Kari has authored 9 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Prasad H. Kari's work include Pharmacogenetics and Drug Metabolism (4 papers), Plant biochemistry and biosynthesis (2 papers) and Cancer therapeutics and mechanisms (1 paper). Prasad H. Kari is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Plant biochemistry and biosynthesis (2 papers) and Cancer therapeutics and mechanisms (1 paper). Prasad H. Kari collaborates with scholars based in United States, United Kingdom and China. Prasad H. Kari's co-authors include Kamlesh P. Vyas, Anthony Y.H. Lu, F.Peter Guengerich, Paul E. Thomas, Xin Xu, F A deLuna, Thomas A. Baillie, Cornelis E. C. A. Hop, Anna Gries and Maria V. Silva and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

In The Last Decade

Prasad H. Kari

9 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prasad H. Kari United States	8	141	84	83	69	65	9	355
PE Rolan United Kingdom	6	63 0.4×	56 0.7×	45 0.5×	34 0.5×	75 1.2×	7	382
Kosei NODA Japan	11	102 0.7×	100 1.2×	49 0.6×	54 0.8×	102 1.6×	32	435
Chang-Hong Jiang China	9	179 1.3×	108 1.3×	49 0.6×	39 0.6×	122 1.9×	14	478
Ken Umehara Japan	13	146 1.0×	102 1.2×	173 2.1×	70 1.0×	150 2.3×	46	536
Jan L. Maxa United States	5	94 0.7×	36 0.4×	30 0.4×	37 0.5×	81 1.2×	9	340
B. Kevin Park United Kingdom	13	157 1.1×	93 1.1×	61 0.7×	30 0.4×	151 2.3×	15	485
Yoshiro Kohno Japan	11	103 0.7×	92 1.1×	25 0.3×	33 0.5×	98 1.5×	36	365
Yukihiro Hirao Japan	11	65 0.5×	81 1.0×	68 0.8×	45 0.7×	95 1.5×	15	352
Angela Äbelö Sweden	12	195 1.4×	106 1.3×	122 1.5×	108 1.6×	123 1.9×	26	541
Robert Iannucci Switzerland	5	128 0.9×	127 1.5×	110 1.3×	110 1.6×	89 1.4×	7	422

Countries citing papers authored by Prasad H. Kari

Since Specialization

Citations

This map shows the geographic impact of Prasad H. Kari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prasad H. Kari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prasad H. Kari more than expected).

Fields of papers citing papers by Prasad H. Kari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prasad H. Kari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prasad H. Kari. The network helps show where Prasad H. Kari may publish in the future.

Co-authorship network of co-authors of Prasad H. Kari

This figure shows the co-authorship network connecting the top 25 collaborators of Prasad H. Kari. A scholar is included among the top collaborators of Prasad H. Kari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prasad H. Kari. Prasad H. Kari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Shou, Magang, Wei Lü, Prasad H. Kari, et al.. (2005). Population pharmacokinetic modeling for enterohepatic recirculation in Rhesus monkey. European Journal of Pharmaceutical Sciences. 26(2). 151–161. 21 indexed citations

Goldberg, Michael R., David Sciberras, Marina De Smet, et al.. (2001). Influence of β‐adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5‐HT_1B/1D agonist: differential effects of propranolol, nadolol and metoprolol. British Journal of Clinical Pharmacology. 52(1). 69–76. 37 indexed citations

Kari, Prasad H., et al.. (2000). Metabolism of A Dopamine D4-Selective Antagonist in Rat, Monkey, and Humans: Formation of A Novel Mercapturic Acid Adduct. Drug Metabolism and Disposition. 28(6). 633–642. 9 indexed citations

Balani, Suresh K., Xin Xu, Byron H. Arison, et al.. (2000). Metabolites of Caspofungin Acetate, a Potent Antifungal Agent, in Human Plasma and Urine. Drug Metabolism and Disposition. 28(11). 1274–1278. 80 indexed citations

Kari, Prasad H., et al.. (1991). Biotransformation of lovastatin. Archives of Biochemistry and Biophysics. 290(2). 355–361. 166 indexed citations

Vyas, Kamlesh P., Prasad H. Kari, & Steven M. Pitzenberger. (1990). Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors. Biochemical and Biophysical Research Communications. 166(3). 1155–1162. 9 indexed citations

Vyas, Kamlesh P., Prasad H. Kari, Regina W. Wang, & Anthony Y.H. Lu. (1990). Biotransformation of lovastatin—III. Biochemical Pharmacology. 39(1). 67–73. 15 indexed citations

Piper, James R., Prasad H. Kari, & Y. Fulmer Shealy. (1981). Synthesis of ³H‐labelled indicine N‐oxide. Journal of Labelled Compounds and Radiopharmaceuticals. 18(11). 1579–1591. 6 indexed citations

Kari, Prasad H., et al.. (1980). Distribution of bratton-marshall-positive material in mice following intravenous injections of nitrosoureas. Cancer Chemotherapy and Pharmacology. 4(4). 243–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact